🔗 Share this article

An underground market for unapproved weight-loss drugs is propelled by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.

Experimental Drug Gaining Popularity Via Social Media

The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Followers are urged to message these accounts directly for source information, while also receiving promotional offers.

Thriving Commerce on Messaging Platforms

Separately, a robust trade exists on Telegram, where groups with numerous of participants share “before and after” images, injection guides and claims of next-day UK delivery. Sellers promote the drug there before directing buyers to WhatsApp for transactions.

Understanding The Experimental Drug

Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could assist individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.

Medical Experts Express Concerns

Nevertheless, physicians and pharmacists have cautions that the distribution of what is still an unlicensed drug in the United Kingdom is worrisome and could lead to individuals administering products of unknown origin.

Several professionals said the demand for the experimental drug could be connected to the increasing cost of approved weight loss products such as Mounjaro.

Regulatory Status and Implementation

Marketing the unapproved drug on social media or Telegram is illegal in the UK, as it is an unlicensed drug that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Some content creators try to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still breach medicines, advertising, and customer laws, risking penalties, legal action or imprisonment.

Service Reaction and Content Removal

According to TikTok, the platform has removed problematic material and banned associated hashtags and search suggestions. The organization stated it was committed to keeping the service secure and investing in enhancing enforcement strategies.

Digital Trading Operations

Research also found communities with up to nine thousand members marketing retatrutide using Telegram's built-in search feature, which operates like a online catalog. Entering “retatrutide” instantly displays groups with thousands of members, filled with images of weight loss, positive reviews and step-by-step instructions for mixing or injecting at home.

After minutes of entering one group, a seller shared WhatsApp details, where most purchases occur. The vendor provided an guidebook and promised shipping within 48 hours. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one asked about body mass, medical conditions or previous experience.

Product Details and Pricing

Inside these communities, messages show black plastic parcels with Royal Mail labels, stating to contain new batches. One message stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at home with sterile water, or pre-filled pens typically priced at £160 for 20mg. When questioned how long a injector should last, sellers give conflicting responses varying between a several days to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for Telegram said it actively moderated harmful material on its service including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are administering substances they can’t verify. Although the research behind retatrutide is sound, these digital versions may not include what they advertise,” said Jason Murphy, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the increase in demand to current price rises for authorized slimming medications such as Mounjaro. “With costs rising, patients are using online platforms. But fake injections are highly dangerous. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she said.

Her staff has previously seen patients harmed by self-injection from unconfirmed sources. “We understand the frustration, but purchasing from messaging apps or communication platforms is gambling with your health,” said Wyllie. “These materials could be impure or improperly measured.”

Manufacturer Statement

A spokesperson from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any government authority globally. “Therefore at this point no one can market [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a company investigational substance not yet approved … may expose users to potentially significant health risks”.